Therefore, simultaneous antagonism of H3R and 5-HT2A/2C may provide synergistic effects in the treatment of depression and psychiatric disorders with additional benefits, such as suicidal ideation reduction, wake-promoting, and pro-cognitive properties. The gene discussed is HRH3; the disease is major depressive disorder.